Literature DB >> 24797287

Michaela Diamant, 11 April 1962-9 April 2014.

Robert J Heine1, Hannele Yki-Järvinen, Steven E Kahn, Daniel H van Raalte.   

Abstract

Mesh：

Year:  2014        PMID： 24797287     DOI： 10.1007/s00125-014-3254-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  12 in total

1.  Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  S E Inzucchi; R M Bergenstal; J B Buse; M Diamant; E Ferrannini; M Nauck; A L Peters; A Tsapas; R Wender; D R Matthews
Journal:  Diabetologia       Date:  2012-04-20       Impact factor: 10.122

Review 2.  Steroid diabetes: from mechanism to treatment?

Authors:  D H van Raalte; M Diamant
Journal:  Neth J Med       Date:  2014-02       Impact factor: 1.422

3.  Prednisolone-induced beta cell dysfunction is associated with impaired endoplasmic reticulum homeostasis in INS-1E cells.

Authors:  Margot M L Linssen; Daniel H van Raalte; Erik J M Toonen; Wynand Alkema; Gerard C van der Zon; Wim H Dokter; Michaela Diamant; Bruno Guigas; D Margriet Ouwens
Journal:  Cell Signal       Date:  2011-06-13       Impact factor: 4.315

4.  Proliferative retinopathy in type 1 diabetes is associated with cerebral microbleeds, which is part of generalized microangiopathy.

Authors:  Jorn Woerdeman; Eelco van Duinkerken; Mike P Wattjes; Frederik Barkhof; Frank J Snoek; Annette C Moll; Martin Klein; Michiel P de Boer; Richard G Ijzerman; Erik H Serné; Michaela Diamant
Journal:  Diabetes Care       Date:  2013-12-06       Impact factor: 19.112

5.  Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial.

Authors:  Michaela Diamant; Luc Van Gaal; Stephen Stranks; Justin Northrup; Dachuang Cao; Kristin Taylor; Michael Trautmann
Journal:  Lancet       Date:  2010-06-26       Impact factor: 79.321

6.  One-year treatment with exenatide vs. insulin glargine: effects on postprandial glycemia, lipid profiles, and oxidative stress.

Authors:  Mathijs C Bunck; Anja Cornér; Bjorn Eliasson; Robert J Heine; Rimma M Shaginian; Yan Wu; Ping Yan; Ulf Smith; Hannele Yki-Järvinen; Michaela Diamant; Marja-Riitta Taskinen
Journal:  Atherosclerosis       Date:  2010-04-29       Impact factor: 5.162

7.  Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging.

Authors:  Luuk J Rijzewijk; Rutger W van der Meer; Hildo J Lamb; Hugo W A M de Jong; Mark Lubberink; Johannes A Romijn; Jeroen J Bax; Albert de Roos; Jos W Twisk; Robert J Heine; Adriaan A Lammertsma; Johannes W A Smit; Michaela Diamant
Journal:  J Am Coll Cardiol       Date:  2009-10-13       Impact factor: 24.094

8.  Glucocorticoid treatment impairs microvascular function in healthy men in association with its adverse effects on glucose metabolism and blood pressure: a randomised controlled trial.

Authors:  Daniël H van Raalte; Michaela Diamant; D Margriet Ouwens; Richard G Ijzerman; Margot M L Linssen; Bruno Guigas; Etto C Eringa; Erik H Serné
Journal:  Diabetologia       Date:  2013-08-11       Impact factor: 10.122

Review 9.  The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?

Authors:  Marcel H A Muskiet; Mark M Smits; Linde M Morsink; Michaela Diamant
Journal:  Nat Rev Nephrol       Date:  2013-12-24       Impact factor: 28.314

Review 10.  Subcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytes.

Authors:  Laura K M Steinbusch; Robert W Schwenk; D Margriet Ouwens; Michaela Diamant; Jan F C Glatz; Joost J F P Luiken
Journal:  Cell Mol Life Sci       Date:  2011-05-06       Impact factor: 9.261
View more
  1 in total

1.  Cerebrospinal fluid levels of Alzheimer's disease biomarkers in middle-aged patients with type 1 diabetes.

Authors:  D Margriet Ouwens; Eelco van Duinkerken; S Niki M Schoonenboom; Daniella Herzfeld de Wiza; Martin Klein; Larissa van Golen; Petra J W Pouwels; Frederik Barkhof; Annette C Moll; Frank J Snoek; Charlotte E Teunissen; Philip Scheltens; Michaela Diamant
Journal:  Diabetologia       Date:  2014-07-18       Impact factor: 10.122
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.